|
| |
Articles
1-93 out of 93 article(s)
| Title |
Author |
Type |
Date |
Words |
| New discovery may help create less toxic anti-HIV drugs. |
|
|
Oct 21, 2009 |
309 |
| New discovery may help create less toxic anti-HIV drugs. |
|
|
Oct 18, 2009 |
309 |
| Tantalisingly close to beating swine f lu; But NHS will double intensive care beds in case. |
|
|
Sep 11, 2009 |
546 |
| 'Tantalisingly close' to beating swine f lu; But NHS to double intensive care beds in case. |
|
|
Sep 11, 2009 |
546 |
| Hypercoagulability due to protein S deficiency in HIV-seropositive patients. |
Orlovic, Dragana; Smego, Raymond A. |
Report |
Aug 1, 2009 |
2296 |
| Patients don't need anti-virals. |
|
|
Jul 18, 2009 |
285 |
| Algae may harbour SARS cure. |
|
|
May 21, 2009 |
261 |
| Mathematical model developed to predict the immune response to influenza. |
|
|
May 14, 2009 |
292 |
| Doctors order city's first victim to stay at home; SWINE FLU: Woman who had just returned from Mexico is diagnosed with the virus. |
|
|
May 7, 2009 |
463 |
| Nine more cases bring total to 27. |
|
|
May 5, 2009 |
483 |
| Free state--we can't pay for ARV needs. |
Bateman, Chris |
Brief article |
Apr 1, 2009 |
310 |
| Late treatment in Africa may disadvantage those with HIV for years. |
Alcorn, Keith; Safreed-Harmon, Kelly |
Report |
Mar 1, 2009 |
1160 |
| Tanzanians still suffer stigma of HIV, even with universal access to antiretrovirals. |
Owur, John |
Report |
Mar 1, 2009 |
832 |
| Elevated liver enzymes in HIV monoinfected patients on HIV therapy: what are the implications? |
Ingiliz, P.; Benhamou, Y. |
Report |
Mar 1, 2009 |
4087 |
| Treatment of acute hepatitis C in HIV-positive individuals: what are the challenges? |
Vogel, Martin; Page, Emma; Nelson, Mark; Rockstroh, Jurgen K. |
Report |
Mar 1, 2009 |
3867 |
| Hepatitis B in HIV patients: what is the current treatment and what are the challenges? |
Soriano, Vincent; Tuma, Paula; Vispo, Eugenia; Labarga, Pablo; Fernandez, Jose Vicente; Medrano, Jos |
Report |
Mar 1, 2009 |
4761 |
| The feasibility of using an 'opt-out' approach to achieve universal HIV testing of tuberculosis patients in Alberta. |
Sturtevant, Doris; Preiksaitis, Jutta; Singh, Ameeta; Houston, Stan; Gill, John; Predy, Gerry; Fishe |
Report |
Mar 1, 2009 |
4139 |
| HHS: Hospitals should stockpile antivirals for HCWs. |
|
|
Mar 1, 2009 |
791 |
| Research and Markets: Good Prospects of Finding a Cure for HIV/AIDS in The Next Decade Reveals Report. |
|
Report |
Feb 10, 2009 |
564 |
| Data from ISENTRESS[R], Merck's HIV Integrase Inhibitor, in Patients Whose HIV is Controlled on a Lopinavir/Ritonavir-Based Therapy Presented at the 16th Conference on Retroviruses and Opportunistic Infections. |
|
Conference news |
Feb 9, 2009 |
8017 |
| Bioalliance Pharma Presents Results on a New Quinoline Family on HIV Integrase Inhibitors at the 16Th Conference on Retroviruses and Opportunistic Infections (CROI). |
|
Conference news |
Feb 6, 2009 |
587 |
| Beating HIV. |
|
Brief article |
Feb 1, 2009 |
173 |
| Government's prison ARV obfuscation 'reprehensible'--Judge. |
Bateman, Chris |
|
Feb 1, 2009 |
445 |
| Aethlon Medical Completes First Medical Device Study to Treat HIV/AIDS. |
|
|
Jan 26, 2009 |
946 |
| Widespread resistance to antiretrovirals among children in the Central African Republic. |
Farham, Bridget |
Brief article |
Jan 1, 2009 |
328 |
| New anti-viral drug may help fight potential bio-terrorism agents. |
|
|
Dec 3, 2008 |
559 |
| New anti-viral drug may help fight potential bio-terrorism agents. |
|
|
Nov 25, 2008 |
559 |
| United States: Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections. |
|
|
Nov 25, 2008 |
123 |
| Avexa Presents Data from Apricitabine and Antibacterial Programs at two International Conferences. |
|
Conference news |
Nov 13, 2008 |
1005 |
| Breastfeeding, antiretroviral prophylaxis and HIV. |
|
Brief article |
Nov 1, 2008 |
284 |
| High early mortality after starting antiretroviral treatment in Africa. |
|
Report |
Nov 1, 2008 |
621 |
| Panacos Presents Phase 2b Bevirimat Data at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. |
|
Conference news |
Oct 26, 2008 |
951 |
| Progenics Announces Progress and Presentations in HIV Therapy Program. |
|
|
Oct 2, 2008 |
1960 |
| United States: SIGA Technologies receives additional $20 million from NIH for ST-246 antiviral therapeutic development. |
|
|
Sep 22, 2008 |
292 |
| HIV and burns. |
Muganza, Adelin |
Clinical report |
Sep 1, 2008 |
1369 |
| U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults. |
|
|
Aug 11, 2008 |
1560 |
| Bionor Immuno Advances HIV Peptide-Based Therapeutic Immunization Program with Start of a Phase IIb Trial in U.S. and Europe. |
|
|
Aug 5, 2008 |
747 |
| Bacterial pneumonia and pandemic influenza planning. |
Gupta, Ravindra K.; George, Robert; Nguyen-Van-Tam, Jonathan S. |
|
Aug 1, 2008 |
4286 |
| Deaths from bacterial pneumonia during 1918-19 influenza pandemic. |
Brundage, John F.; Shanks, G. Dennis |
|
Aug 1, 2008 |
4539 |
| FDA Approves Energex Systems, Inc. Non-Drug Therapy For HIV Research. |
|
|
Jul 14, 2008 |
652 |
| Dual drug class resistance in two-thirds of those failing antiretroviral therapy in South Africa. |
Farham, Bridget |
Report |
Jul 1, 2008 |
581 |
| Prisoners to get HIV drugs. |
Bateman, Chris |
Brief article |
Jul 1, 2008 |
174 |
| There are many clinically important interactions between HIV and malaria. |
Cohen, Cheryl |
Report |
Jun 1, 2008 |
2746 |
| First human transmission of bird flu: recent tests show the first probable case of human transmission of bird flu and have prompted calls for urgent investigation to assess whether avian influenza A has acquired the ability to spread more easily among people. |
|
|
Jun 1, 2008 |
461 |
| Virostatics Doses First Patient in Phase IIa Trial of VS411 for the Treatment of HIV Infection. |
|
Clinical report |
May 12, 2008 |
633 |
| Alnylam Initiates Phase II Trial to Evaluate Safety and Tolerability of ALN-RSV01 in Adult Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus (RSV) Infection. |
|
|
Apr 9, 2008 |
1423 |
| Ziagen, Videx under safety review by FDA and EMEA. |
|
|
Apr 8, 2008 |
522 |
| Monitor patients before treatment to improve survival in HIV. |
Farham, Bridget |
Report |
Apr 1, 2008 |
691 |
| Health services given boost to combat AIDS. |
Bateman, Chris |
Brief article |
Apr 1, 2008 |
168 |
| Alnylam Achieves First Human Proof of Concept for an RNAi Therapeutic with GEMINI Study. |
|
|
Feb 29, 2008 |
1692 |
| Bevirimat Data Presented at 15th Conference on Retroviruses and Opportunistic Infections. |
|
Conference news |
Feb 6, 2008 |
744 |
| Alnylam Reports Positive Phase II Data for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection. |
|
|
Jan 23, 2008 |
1089 |
| Adamantane-resistant influenza infection during the 2004-05 season. |
Rahman, Mahbubur; Bright, Rick A.; Kieke, Burney A.; Donahue, James G.; Greenlee, Robert T.; Vanderm |
|
Jan 1, 2008 |
2804 |
| Hiding in plain sight: the role of contraception in preventing HIV. |
Cohen, Susan A. |
|
Jan 1, 2008 |
2361 |
| Alnylam Reports Continued Progress in Clinical Development of ALN-RSV01 for the Treatment of Respiratory Syncytial Virus (RSV) Infection. |
|
Clinical report |
Dec 13, 2007 |
1343 |
| Obstacles to effective treatment for HIV and Aids. |
Williams, Kari |
Report |
Dec 1, 2007 |
1045 |
| Review of molecular methods for medical microbiology testing. |
Evans, Gloria |
|
Nov 1, 2007 |
9047 |
| Novel Antiviral HIV Drug SpirH(TM) Offers New Hope for AIDS Patients Worldwide. |
|
|
Oct 9, 2007 |
903 |
| Exclusive Agreement Announced Between Quidel Corporation and Roche Pharma AG. |
|
|
Sep 26, 2007 |
996 |
| Preclinical Data on FermaVir's FV-100 Presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. |
|
Conference news |
Sep 19, 2007 |
1132 |
| Alnylam Awarded $38.6 Million U.S. Government Contract to Develop RNAi Therapeutics for Biological Threats. |
|
|
Aug 9, 2007 |
1242 |
| Second Phase III Study Evaluating Gilead's Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint. |
|
|
Jun 25, 2007 |
1680 |
| Phase III Study Evaluating Gilead's Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint. |
|
|
Jun 6, 2007 |
1741 |
| Paths of glory: pathways to wellness, a holistic health center in Boston, mixes up a different HIV cocktail. |
Henderson, William |
|
Apr 10, 2007 |
708 |
| New approaches and resolve may define the future of the global HIV pandemic. |
Daar, Eric S. |
|
Jan 1, 2007 |
1524 |
| AIDS treatment strategy shift. |
|
Brief article |
Nov 1, 2006 |
191 |
| Cognitive effects of HIV in children. |
|
Brief article |
Nov 1, 2006 |
204 |
| Bristol-Myers Squibb Company and Medivir AB Announce Worldwide Collaboration to Develop and Commercialize MIV-170 for the Treatment of HIV-1 Infection in Adults. |
|
|
Sep 13, 2006 |
636 |
| Drugs add years of life for HIV-infected. |
Arias, Donya C. |
Brief article |
Aug 1, 2006 |
138 |
| New Data Show FUZEON(R) Continues to Provide Significant Immune System Benefits in Patients Despite Ongoing Viral Replication. |
|
|
Jun 26, 2006 |
1591 |
| Reversible right ventricular dysfunction in HIV-infected patients. |
Barbaro, Giuseppe |
|
Mar 1, 2006 |
777 |
| Pandemic infection control practices for HCWs. |
|
|
Mar 1, 2006 |
436 |
| Data Indicate That Whole-Inactivated HIV-1 Immunogen Induces HIV-Specific Immune Responses in HIV-Infected, HAART-Naive Patients; Final Data from IMNR.OB's Italian Study Presented in Poster at CROI Annual Meeting. |
|
|
Feb 10, 2006 |
1446 |
| Preliminary 24-Week Data Evaluating the Impact of Switching from Twice-Daily Combivir(R) to Once-Daily Truvada(R) in Patients with HIV Presented at 10th European AIDS Conference. |
|
|
Nov 17, 2005 |
1829 |
| 40m infected worldwide. |
|
|
Nov 14, 2005 |
283 |
| Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: guidelines on care, treatment and support. |
|
|
Nov 1, 2005 |
82 |
| Imiquimod. |
Wooten, James M. |
Editorial |
Sep 1, 2005 |
757 |
| Ten years of HAART. |
Harrington, Mark |
|
Jun 22, 2005 |
4496 |
| Therapeutic and diagnostic advances in the HAART era. |
Cheng, Ben |
|
Jun 22, 2005 |
2043 |
| Guidelines for nonoccupational HIV prophylaxis. |
Finn, Robert |
|
Jun 1, 2005 |
642 |
| Niacin for dyslipidemia. |
|
Brief Article |
Oct 1, 2004 |
207 |
| Measuring health-related quality of life: a comparison between people living with aids and police on active duty. |
Moller, Paul H.; Smit, Ria |
|
Jul 1, 2004 |
6926 |
| Third world disease affects everyone. |
Sachs, Jeffrey D. |
|
May 1, 2004 |
1009 |
| HIV drugs change cognitive impairment risk. |
Boschert, Sherry |
|
May 1, 2004 |
562 |
| A 13-week subchronic intravaginal toxicity study of pokeweed antiviral protein in mice. |
D'Cruz, O.J.; Waurzyniak, B.; Uckun, F.M. |
|
Apr 1, 2004 |
7166 |
| Proven ways to relieve the terrible pain of shingles. |
Fuchs, Nan Kathyrn |
|
Mar 1, 2002 |
1764 |
| Effective management of hepatitis C molecular testing improves test use without compromising patient management. (State of the Art in Clinical and Anatomic Pathology). |
Kukuczka, Sara; Grosso, Leonard E. |
|
Jan 1, 2002 |
2033 |
| FDA Gives Salvage Therapy Testing a Push Forward. |
Bass, Emily |
|
Mar 23, 2001 |
2345 |
| The case against a when-to-start antiretroviral therapy trial. |
Schouten, Jeffrey T |
Brief Article |
Mar 22, 2001 |
973 |
| HHS guidelines support genotypic testing as an adjunct to treatment of HIV. |
|
Brief Article |
Apr 1, 2000 |
115 |
| Protease inhibitors may cause diabetes, FDA warns. |
|
|
Aug 1, 1997 |
467 |
| New cold sore cream on the market. |
Seppa, Nathan |
Brief Article |
May 31, 1997 |
212 |
| Antiviral drug could cut chicken pox short. |
Raloff, Janet |
|
Nov 30, 1991 |
513 |
|
